Vr54pgo5aetu313u0ib2tncl

.
A03 - MR. KAMESH KUMAR GUPTA - BAI KA

BAGH CC
Name : Mrs. RUKMANI GUPTA Collected : 6/7/2022 12:40:00PM

Received : 6/7/2022 12:47:37PM
Lab No. : 333099516 Age: 71 Years Gender: Female Reported : 6/7/2022 8:19:16PM
A/c Status : P Ref By : SELF Report Status : Final
Test Name Results Units Bio. Ref. Interval
SwasthFit Super 2
COMPLETE BLOOD COUNT;CBC

(Electrical Impedence,Manual)
Hemoglobin 9.30 g/dL 12.00 - 15.00
Packed Cell Volume (PCV) 29.00 % 36.00 - 46.00
RBC Count 3.60 mill/mm3 3.80 - 4.80
MCV 80.60 fL 83.00 - 101.00
MCH 25.80 pg 27.00 - 32.00
MCHC 32.10 g/dL 31.50 - 34.50
Red Cell Distribution Width (RDW) 16.70 % 11.60 - 14.00
Total Leukocyte Count (TLC) 7.98 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)

Segmented Neutrophils 67.90 % 40.00 - 80.00
Lymphocytes 22.60 % 20.00 - 40.00
Monocytes 4.60 % 2.00 - 10.00
Eosinophils 4.50 % 1.00 - 6.00
Basophils 0.40 % <2.00
Absolute Leucocyte Count
Neutrophils 5.42 thou/mm3 2.00 - 7.00
Lymphocytes 1.80 thou/mm3 1.00 - 3.00
Monocytes 0.37 thou/mm3 0.20 - 1.00
Eosinophils 0.36 thou/mm3 0.02 - 0.50
Basophils 0.03 thou/mm3 0.02 - 0.10
Platelet Count 319 thou/mm3 150.00 - 410.00
Mean Platelet Volume 9.9 fL 6.5 - 12.0
Note
*333099516*
Page 1 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

FEVER PANEL - BASIC
HEMOGRAM
(Electrical Impedence,Manual,Westergr)
Hemoglobin 9.30 g/dL 12.00 - 15.00
Packed Cell Volume (PCV) 29.00 % 36.00 - 46.00
RBC Count 3.60 mill/mm3 3.80 - 4.80
MCV 80.60 fL 83.00 - 101.00
MCH 25.80 pg 27.00 - 32.00
MCHC 32.10 g/dL 31.50 - 34.50
Red Cell Distribution Width (RDW) 16.70 % 11.60 - 14.00
Total Leukocyte Count (TLC) 7.98 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)

Segmented Neutrophils 67.90 % 40.00 - 80.00
Lymphocytes 22.60 % 20.00 - 40.00
Monocytes 4.60 % 2.00 - 10.00
Eosinophils 4.50 % 1.00 - 6.00
Basophils 0.40 % <2.00
Absolute Leucocyte Count
Neutrophils 5.42 thou/mm3 2.00 - 7.00
Lymphocytes 1.80 thou/mm3 1.00 - 3.00
Monocytes 0.37 thou/mm3 0.20 - 1.00
Eosinophils 0.36 thou/mm3 0.02 - 0.50
Basophils 0.03 thou/mm3 0.02 - 0.10
*333099516*
Page 2 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

Platelet Count 319 thou/mm3 150.00 - 410.00
Mean Platelet Volume 9.9 fL 6.5 - 12.0
ESR 63 mm/hr 0 - 20
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
*333099516*
Page 3 of 13
.
A03 - PTS CHOWK, SAMAN

REWA MP
Name : Mr. PUSHPARAJ Collected 8/4/2024 12:40:00PM

Received 8/4/2024 12:47:37PM
Lab No. : 333099516 Age: 30 Years Gender: male Reported 8/4/2024 8:19:16PM
A/c Status : P Ref By : Dr. ANIL Report Status : Final
MALARIA , P.VIVAX AND P.FALCIPARUM ANTIGEN

(ICT)
Plasmodium falciparum antigen Detected
Plasmodium vivax antigen Detected
Note: 1. In the gametogony stage, P.falciparum may not be secreted. Such carriers may show falsely
negative result
Type your textThis test is used to indicate therapeutic response. Positive test results 5-10 days post treatment
2.
indicate the possibility of a resistant strain of malaria
Comments
Malaria is a protozoan parasitic infection, prevalent in the Tropical & Subtropical areas of the world. Four
species of plasmodium parasites are responsible for malarial infections in humans viz. P.falciparum, P.vivax,
P.ovale & P.malariae. Falciparum infections are associated with Cerebral malaria and drug resistance
whereas vivax infection is associated with high rate of infectivity and relapse. Differentiation between
P.falciparum and P.vivax is of utmost importance for better patient management and speedy recovery.
WIDAL TEST, SERUM

(Slide Agglutination)
Salmonella typhi O (TO) Non Reactive
Salmonella typhi H (TH) Non Reactive
Salmonella paratyphi A, H (AH) Non Reactive
Salmonella paratyphi B, H (BH) Non Reactive
Interpretation
-------------------------------------------------------------------------------------
| RESULT | REMARKS |
|--------------|----------------------------------------------------------------------|
| Reactive | Indicates presence of IgM & IgG antibodies against Salmonella spp. |
|--------------|----------------------------------------------------------------------|
| Non-Reactive | Indicates absence of IgM & IgG antibodies against Salmonella spp. |
-------------------------------------------------------------------------------------
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*333099516*
.

BAGH CC

Received : 6/7/2022 12:47:37PM

Note:
1.Titres ≥1:80 of “O” antigen & ≥1:160 of “H” antigen for Salmonella typhi and titres ≥1:80 of “H” antigen for
Salmonella paratyphi A & B are significant.
2. Rising titres in paired samples taken 7-10 days apart are more significant than a single test.
3. Reactive results indicates ongoing or recent infection by Salmonella spp. and the diagnosis should be
confirmed by gold standard test such as Blood culture prior to start of antibiotics.
4. The reactivity will vary with stage of the disease with appearance in 1st week to increase in titres till end
of 4th week post which it starts decreasing.
5. In TAB vaccinated patients, high titres of H antibody of ≥1:160 to each of Salmonellae is observed. They
tend to persist for many months and even years while O antibody shows lower titres and disappears
within 6 months.
6. Antibiotic treatment during 1st week before the appearance of antibodies tend to supress the immune
response in the form of no or decreasing antibody levels.
7. False positive results/anamnestic response may be seen in patients with past enteric infection during
unrelated fevers like Malaria, Influenzae etc. in the form of transient rise in H antibody in Widal test.
8. False negative results may be due to processing of sample collected early in the course of disease (1st
week) and immunosuppression.
9. Test conducted on serum.
Uses
· To diagnose infection due to Salmonella spp. (Enteric fever).
· To monitor the progression of disease.
· To assess the response to therapy (decreasing titres) in patients being treated for Enteric fever.
GLUCOSE, FASTING (F), PLASMA Sample Not Received
SNR01-
(Hexokinase)
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*333099516*
Page 5 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

URINE EXAMINATION, ROUTINE; URINE, R/E
(Dipstick, Microscopy)
Physical
Colour Light Yellow Pale yellow
Specific Gravity <=1.005 1.001 - 1.030
pH 7 5.0 - 8.0
Chemical
Proteins Negative Negative
Glucose Negative Negative
Ketones Negative Negative
Bilirubin Negative Negative
Urobilinogen Negative Negative
Leucocyte Esterase Negative Negative
Nitrite Negative Negative
Microscopy
R.B.C. Negative 0.0 - 2.0 RBC/hpf
Pus Cells 0-1 WBC/HPF 0-5 WBC / hpf
Epithelial Cells Few 0.0 - 5.0 Epi

cells/hpf
Casts None seen None seen/Lpf
Crystals Negative None seen
Others None seen None seen
PatientReportSCSuperPanel.URINE_EXAMINATION_SC (Version: 6) Page 6 of 13
*333099516*
.

BAGH CC

Received : 6/7/2022 12:47:37PM
LIVER & KIDNEY PANEL, SERUM

(Reflectance Photometry,Direct ISE)
Bilirubin Total 0.26 mg/dL <1.10
Bilirubin Direct 0.12 mg/dL <0.20
Bilirubin Indirect 0.14 mg/dL <1.10
AST (SGOT) 13.1 U/L <32
ALT (SGPT) <10.0 U/L <33
GGTP 12.0 U/L <42.00
Alkaline Phosphatase (ALP) 100.00 U/L <141
Total Protein 6.81 g/dL 6.40 - 8.30
Albumin 3.76 g/dL 3.97 - 4.94
A : G Ratio 1.23 0.90 - 2.00
Urea 41.10 mg/dL 21.00 - 43.00
Creatinine 1.37 mg/dL <0.90
Uric Acid 6.70 mg/dL 2.4 - 5.7
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)
*333099516*
Page 7 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

Calcium, Total 8.95 mg/dL 8.8 - 10.2
Phosphorus 4.74 mg/dL 2.6 - 4.5
Sodium 144.00 mEq/L 136.00 - 145.00
Potassium 4.70 mEq/L 3.5 - 5.1
Chloride 105.60 mEq/L 97 - 107
ADVICE: CKD RISK MAP

KDIGO guideline, 2012 recommends Chronic Kidney disease (CKD) should be classified based on cause,
GFR category and albuminuria (ACR) category. GFR & ACR category combined together reflect risk of
progression and helps clinician to identify individuals who are progressing at more rapid rate than anticipated
*333099516*
Page 8 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC)
HbA1c 6.8 % 4.00 - 5.60
Estimated average glucose (eAG) 148 mg/dL
Interpretation
HbA1c result is suggestive of Diabetes/ well controlled Diabetes in a known Diabetic
Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------
PatientReportSCSuperPanel.HBELECTRO_SC (Version: 7)
*333099516*
Page 9 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM
THYROID PROFILE,TOTAL, SERUM

(ECLIA)
T3, Total 0.75 ng/mL 0.80 - 2.00
T4, Total 7.47 µg/dL 5.10 - 14.10
TSH 4.90 µIU/mL 0.27 - 4.20
Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
*333099516*
Page 10 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM
LIPID SCREEN, SERUM

(CHO-POD)
Cholesterol, Total 149.90 mg/dL <200
Triglycerides 96.70 mg/dL <150.00
HDL Cholesterol 63.10 mg/dL >50
LDL Cholesterol, Calculated 67.46 mg/dL <100.00
VLDL Cholesterol,Calculated 19.34 mg/dL <30.00
Non-HDL Cholesterol 87 mg/dL <130
Interpretation
------------------------------------------------------------------------------------------------
| REMARKS | TOTAL CHOLESTEROL | TRIGLYCERIDE | LDL CHOLESTEROL | NON HDL CHOLESTEROL |
| | in mg/dL | in mg/dL | in mg/dL | in mg/dL |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Optimal | <200 | <150 | <100 | <130 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Above Optimal | - | - | 100-129 | 130 - 159 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Borderline High | 200-239 | 150-199 | 130-159 | 160 - 189 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| High | >=240 | 200-499 | 160-189 | 190 - 219 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Very High | - | >=500 | >=190 | >=220 |
------------------------------------------------------------------------------------------------
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. NLA-2014 recommends a complete lipoprotein profile as the initial test for evaluating cholesterol.
3. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
*333099516*
Page 11 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

4. NLA-2014 identifies Non HDL Cholesterol(an indicator of all atherogeniclipoproteins such as LDL ,
VLDL, IDL, Lpa, Chylomicron remnants)along with LDL-cholesterol as co- primary target for
cholesterol lowering therapy. Note that major risk factors can modify treatment goals for LDL &Non
HDL.
5. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have
been achieved
6. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among patients
with moderate risk for ASCVD for risk refinement
Treatment Goals as per Lipid Association of India 2016

----------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-----------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL | LDL CHOLESTEROL | NON HDL CHLOESTEROL |
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) |
|----------|------------------|----------------------|------------------|----------------------|
| Very | <50 | <80 | >=50 | >=80 |
| High | | | | |
|----------|------------------|----------------------|------------------|----------------------|
| High | <70 | <100 | >=70 | >=100 |
|----------|------------------|----------------------|------------------|----------------------|
| Moderate | <100 | <130 | >=100 | >=130 |
|----------|------------------|----------------------|------------------|----------------------|
| Low | <100 | <130 | >=130* | >=160* |
----------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months
Dr. Anveksha Sachan

MD (Pathology)
Chief of Laboratory
Dr Lal PathLabs Ltd
*333099516*
Page 12 of 13
.

BAGH CC

Received : 6/7/2022 12:47:37PM

-------------------------------End of report --------------------------------
AHEEEHAPMKHIBLFNLKANNLPCBILLJCECCKLCIKPLPKEDFFFAPPAHEEEHA
BNFFFNBPAPBKIPNGFGEOJGAPAOAHFHAKBKNOBCJCJLEKMGJHNPBNFFFNB
CIEGGHFLNOOMJBJOPFIAAJHFJCFEHEDHLKPHENFLMLKIOEFLBLHDEHANP
DJHHMEFNBPKIEDIPAKNELFMFAFHKALBFJIFFPBPAKCLJPDNLINFBKEMEK
JBCALHFJONJFDIAHJFNCKPJDJENJKBCHKKMDCCEIPLKGKPNGKFFFOPKMH
DCCBBEFNNICGDIFKIPEEOIPBADHFOFAINCFCBKDLALIKOMNALNEJPGMKD
PLIMIJFJILOPBONIEKMNNHGHIHAFJBALPPOPBLMCKJCHKJNIIJNJMDILD
NJJJAMFNBKMICALJGANHDJNILLBMFMBFOFCCAMNNIIKNOPNOBNFMAHILL
NKILOHFICGOGFAAELNMIHIMKHGEFEKFBJFFKAKOFOOBIOCNKDJPHNEKLJ
ONFGCEFCEDBJJDCFBIKFGPNGIDFKPNJHKEPHCLPLNKCKIGEOCMGKHMEJP
JLIKOLFLGKCBMNCMPBJLJJEEINMLHLJBJMFEBFOFPNDMKPFKEPCIGKIMG
EOICGJFCPLDDEHKMHHGAFMBEIEOPPFOFBCFPBLNOOLJBIKNIOKONHDICL
MNNNNNEPKHDMBOCJOCFLHGDHJBAHFHABLKPFCMNLMKJCLFNOAHFHAHIKL
APBBBPAPBHEAEJBEFOBKCBGFAHFCHHCAONFEOLOGOLMHNLNNEDFFCBKHH
HHHHHHHPHHPPHPPPHHPPPPHPHHPPPPPPPPPHHHHPPHHHPHPHHHHHPHPHP
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring
Physician.ŸSample repeats are accepted on request of Referring Physician within 7 days post reporting.ŸReport delivery may be delayed due to
unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for derivation of exact value .
Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe Courts/Forum at Delhi shall have
exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico legal purposes .
ŸContact customer care Tel No. +91-11-39885050 for all queries related to test results.
(#) Sample drawn from outside source.
*333099516*
Page 13 of 13

Vr54pgo5aetu313u0ib2tncl

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Vr54pgo5aetu313u0ib2tncl

Uploaded by

Copyright:

Available Formats

.

A03 - MR. KAMESH KUMAR GUPTA - BAI KA

Name : Mrs. RUKMANI GUPTA Collected : 6/7/2022 12:40:00PM

Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT;CBC

Hemoglobin 9.30 g/dL 12.00 - 15.00

Packed Cell Volume (PCV) 29.00 % 36.00 - 46.00

RBC Count 3.60 mill/mm3 3.80 - 4.80

MCV 80.60 fL 83.00 - 101.00

MCH 25.80 pg 27.00 - 32.00

MCHC 32.10 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 16.70 % 11.60 - 14.00

Total Leukocyte Count (TLC) 7.98 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Mean Platelet Volume 9.9 fL 6.5 - 12.0

A03 - MR. KAMESH KUMAR GUPTA - BAI KA

Name : Mrs. RUKMANI GUPTA Collected : 6/7/2022 12:40:00PM

Test Name Results Units Bio. Ref. Interval

2. Test conducted on EDTA whole blood

Hemoglobin 9.30 g/dL 12.00 - 15.00

Packed Cell Volume (PCV) 29.00 % 36.00 - 46.00

RBC Count 3.60 mill/mm3 3.80 - 4.80

MCV 80.60 fL 83.00 - 101.00

MCH 25.80 pg 27.00 - 32.00

MCHC 32.10 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 16.70 % 11.60 - 14.00

Total Leukocyte Count (TLC) 7.98 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

A03 - MR. KAMESH KUMAR GUPTA - BAI KA

Name : Mrs. RUKMANI GUPTA Collected : 6/7/2022 12:40:00PM

Test Name Results Units Bio. Ref. Interval

Mean Platelet Volume 9.9 fL 6.5 - 12.0

2. Test conducted on EDTA whole blood

A03 - PTS CHOWK, SAMAN

Name : Mr. PUSHPARAJ Collected 8/4/2024 12:40:00PM

Test Name Results Units Bio. Ref. Interval

MALARIA , P.VIVAX AND P.FALCIPARUM ANTIGEN

Plasmodium falciparum antigen Detected

Plasmodium vivax antigen Detected

WIDAL TEST, SERUM

Salmonella typhi O (TO) Non Reactive

Salmonella typhi H (TH) Non Reactive

Salmonella paratyphi A, H (AH) Non Reactive

Salmonella paratyphi B, H (BH) Non Reactive

A03 - MR. KAMESH KUMAR GUPTA - BAI KA

Name : Mrs. RUKMANI GUPTA Collected : 6/7/2022 12:40:00PM

Test Name Results Units Bio. Ref. Interval

A03 - MR. KAMESH KUMAR GUPTA - BAI KA

Name : Mrs. RUKMANI GUPTA Collected : 6/7/2022 12:40:00PM

Test Name Results Units Bio. Ref. Interval

Colour Light Yellow Pale yellow

Specific Gravity <=1.005 1.001 - 1.030

Proteins Negative Negative

Glucose Negative Negative

Ketones Negative Negative

Bilirubin Negative Negative

Urobilinogen Negative Negative

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

R.B.C. Negative 0.0 - 2.0 RBC/hpf

Pus Cells 0-1 WBC/HPF 0-5 WBC / hpf

Epithelial Cells Few 0.0 - 5.0 Epi

Crystals Negative None seen